InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: EndoTarget post# 331350

Friday, 08/16/2019 11:06:43 PM

Friday, August 16, 2019 11:06:43 PM

Post# of 346002
That is big accumulation for the Special Situations group -AWM 527 Madison Ave picking up a boat load of CDMO

Maybe Patrick Crutcher across at 520 Madison Ave with Chimera Research realized how foolish the comments were...and now to green signal all aboard...heck, even Merck on 3 trials now with PS Targeting so they see something very good with the IP

The new Avid BODs have a very unique business model...a full fledged CDMO and milestones royalties Biomarkers etc etc from the PS Targeting IP ( something NO other CDMO has and once fully in motion...the price will Trump all other CDMO buyouts )

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News